甲酸IV改善功能,并减轻慢性淋巴结核炎的老鼠的损伤和炎症
Dong Zhang1, ZongYing Li1, Yuan Gao1
1The First Department of Nephrology, Cangzhou Central Hospital, Hebei Province, China.
Turkish journal of biology = Turk biyoloji dergisi
|August 2, 2023
概括
甲酸IV (AS-IV) 是一种来自传统中医药的化合物,有效治疗老鼠的慢性淋巴结膜炎 (CGN). AS-IV通过调节miR-181d-5p/CSF1通路来起作用,减少炎症并改善功能.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
背景情况:
- 甲酸IV (AS-IV) 是来自*Astragalus membranaceus*的纯化素,在传统医学中使用.
- 慢性淋巴结膜炎 (CGN) 是一种严重的病,需要有效的治疗策略.
研究的目的:
- 调查AS-IV的治疗机制在慢性淋巴结膜炎 (CGN) 的老鼠模型中.
- 阐明AS-IV在调节CGN中的功能,炎症和细胞行为的作用.
主要方法:
- 建立了一种化牛血清白蛋白诱导的CGN大鼠模型,并用不同剂量的AS-IV治疗.
- 评估功能,炎症透和介质细胞增殖,细胞循环和炎症.
- 研究了miR-181d-5p和CSF1在AS-IV治疗效果中的参与.
主要成果:
- 在CGN大鼠中,AS-IV显著缓解了功能障碍,组织学损伤和炎症.
- 通过改变细胞周期进展 (延长G0-G1,缩短S阶段),AS-IV抑制了由脂多糖诱导的老鼠介质细胞 (RMC) 的增殖和炎症.
- AS-IV促进了miR-181d-5p的表达,随后抑制了CSF1,这是其保护作用至关重要的机制.
结论:
- AS-IV 显示出对慢性淋巴结膜炎的显著治疗潜力.
- AS-IV的保护作用通过miR-181d-5p/CSF1轴进行介导.
- 准miR-181d-5p/CSF1通路为治疗CGN提供了一个有希望的策略.
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
35
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
01:24Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
01:25Antihypertensive Drugs: Direct Renin Inhibitors
684
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
684
01:28Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
01:29Acute Kidney Injury II: Pathophysiology
31
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
31